Saiama N. Waqar

Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study

Susan M. Domchek, Sophie Postel‐Vinay, Seock‐Ah Im et al. · The Lancet Oncology · 2020 · 435 citations

Phase 1/2, Breast Oncology, Oncology +8

Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Apar Kishor Ganti, Billy W. Loo, M. Bassetti et al. · Journal of the National Comprehensive Cancer Network · 2021 · 431 citations · Full text

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer

M. Catherine Pietanza, Saiama N. Waqar, Lee M. Krug et al. · Journal of Clinical Oncology · 2018 · 387 citations · Full text

Non–small-cell Lung Cancer With Brain Metastasis at Presentation

Saiama N. Waqar, Pamela Samson, Clifford G. Robinson et al. · Clinical Lung Cancer · 2018 · 244 citations · Full text

Brain Metastases, Medicine, Brain Metastasis +4

Clinical next‐generation sequencing in patients with non–small cell lung cancer

Ian S. Hagemann, Siddhartha Devarakonda, Christina M. Lockwood et al. · Cancer · 2014 · 238 citations